The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127558321 12755832 1 I 201512 20160531 20160916 20160916 PER US-ASTRAZENECA-2016SE58925 ASTRAZENECA 865.00 MON F Y 81.20000 KG 20160916 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127558321 12755832 1 PS BYDUREON EXENATIDE 1 Subcutaneous 24 MG FN0142 22200 2 MG /wk
127558321 12755832 2 SS BYETTA EXENATIDE 1 Unknown 5 U 0 SOLUTION FOR INJECTION IN PRE-FILLED PEN
127558321 12755832 3 SS BYETTA EXENATIDE 1 Unknown 10 U 0 SOLUTION FOR INJECTION IN PRE-FILLED PEN
127558321 12755832 4 SS LISINOPRIL. LISINOPRIL 1 Oral U U 0 10 MG TABLET QD
127558321 12755832 5 SS LISINOPRIL. LISINOPRIL 1 Oral U U 0 20 MG TABLET QD
127558321 12755832 6 SS LISINOPRIL. LISINOPRIL 1 Oral U U 0 40 MG TABLET QD
127558321 12755832 7 SS LISINOPRIL. LISINOPRIL 1 Oral U U 0 40 MG TABLET QD
127558321 12755832 8 SS LISINOPRIL. LISINOPRIL 1 Oral U U 0 20 MG TABLET QD
127558321 12755832 9 SS LISINOPRIL. LISINOPRIL 1 Oral U U 0 20 MG TABLET QD
127558321 12755832 10 SS METFORMIN HCL METFORMIN HYDROCHLORIDE 1 Oral 750 MG, NON-AZ PRODUCT 0
127558321 12755832 11 C IMODIUM LOPERAMIDE HYDROCHLORIDE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127558321 12755832 1 Type 2 diabetes mellitus
127558321 12755832 2 Type 2 diabetes mellitus
127558321 12755832 3 Type 2 diabetes mellitus
127558321 12755832 4 Renal disorder
127558321 12755832 5 Renal disorder
127558321 12755832 6 Renal disorder
127558321 12755832 7 Renal disorder
127558321 12755832 8 Renal disorder
127558321 12755832 9 Renal disorder
127558321 12755832 10 Type 2 diabetes mellitus
127558321 12755832 11 Diarrhoea

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
127558321 12755832 Blood creatinine increased
127558321 12755832 Blood glucose increased
127558321 12755832 Circumstance or information capable of leading to medication error
127558321 12755832 Cold sweat
127558321 12755832 Device difficult to use
127558321 12755832 Device malfunction
127558321 12755832 Diabetes mellitus
127558321 12755832 Diarrhoea
127558321 12755832 Drug hypersensitivity
127558321 12755832 Fall
127558321 12755832 Feeling abnormal
127558321 12755832 Feeling jittery
127558321 12755832 Hypertension
127558321 12755832 Nausea
127558321 12755832 Pharyngeal disorder
127558321 12755832 Underdose
127558321 12755832 Vertigo

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127558321 12755832 1 20160310 0
127558321 12755832 7 201512 20160514 0
127558321 12755832 8 20160515 20160520 0
127558321 12755832 9 20160521 0